Communicable disease, nosSNOMED Notion

https://iris.who.int/handle/10665/376078
2024
Switzerland
technical report
Paraneoplastic Syndrome is Not Present
communicable disease control
Caffeine Not Routinely Consumed
Has No Sibling
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Chief Complaint Not Caused by Trauma
Local Anesthesia Agents were not Administered
health personnel
Radiation History Negative
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
Physician Diagnosed Diabetes Absent
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
Additional Surgery for New Tumor Event Absent
principal
Chemical/Occupational Exposure Absent
EGFR Gene Amplification Negative
EGFR Amplification Analysis Was Not Performed
Cancer History Absent
Preoperative IV Antiemetics were not Administered
New Tumor Event After Initial Treatment Absent
Minor Criteria for Rheumatic Heart Disease Not Present
Therapeutic Ionizing Radiation to Head History Absent
Optimization
PTEN Gene Mutation Negative
Adjuvant Post-operative Radiation Therapy Was Not Administered
PDGFRA Mutation Analysis Was Not Performed
Routine Cytogenetics Were not Completed
10q23/PTEN Locus Deletion Analysis Was Not Performed
Adjuvant Post-operative Immunological Therapy Was Not Administered
Not Lost to Follow-Up
NON Mouse
Another Form of Birth Control was not Used
No History of Congenital Heart Disease
ATRX Gene Mutation Negative
Improved
Medication Not Taken
First Degree Family History of Primary Brain Tumor Negative
No History of Non-Cardiac Surgery
Preoperative IV Sedation was Not Administered
First Degree Family History Thyroid Cancer Negative
Regional Anesthesia was not Administered
Any Metastatic Diagnosis Absent
delivery of health care
1p/19q Deletion Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
BRAF Mutation Analysis Was Not Performed
Negation
Neither Case or Control Status
kenya
Chemotherapy Not Received
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Health Care Delivery
Noncommunicable Diseases
EGFR Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
No History of Myopathy
Delegate Action
First Degree Family History Cancer Negative
PTEN Mutation Analysis Was Not Performed
Enhance
health services
Additional Immunohistochemistry Was Not Performed
KRAS Mutation Analysis Was Not Performed
health benefits
Chief Complaint was Not Witnessed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
Primary Care
Unemployed
Lymph Node Dissection Was Not Performed
History of Medical Treatment Absent
SDH Complex Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
IDH Family Wildtype
Radiation Therapy Not Received
IV Anesthesia was not Administered
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
No History of Kawasaki Disease
No History of Neonatal Complication
Norway
No Response to Intervention for Kawasaki Disease
ALK Rearrangement Analysis Was Not Performed
Other Preoperative IV Medications were not Administered
New Disease is not Multifocal
Preoperative IV Opiates were not Administered
No Known History of Alcohol Use
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Tumor Progression Absent After Initial Treatment
RET Rearrangement Analysis Was Not Performed
Share
Documentation Absent
Shared
primary health care
State or Local Health Department
Additional Molecular Studies Were Not Performed
NRAS Mutation Analysis Was Not Performed
insurance benefits
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Adjuvant I-131 Therapy Negative
MET Mutation Analysis Was Not Performed
Research Personnel
BRAF Rearrangement Analysis Was Not Performed
Evidence of Disease Absent after Completion of Therapy
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
Preoperative IV Antacids were not Administered
No Known History of Illicit Drug Use
MGMT Promoter Methylation Testing Was Not Performed
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
ERBB2 Mutation Analysis Was Not Performed
Regular Smokeless Tobacco Use for Six Weeks or More Negative
Hypertension Absent
On Staff
Care Of
No History of Rheumatic Fever
History of Colorectal Cancer Negative
NF1 Mutation Analysis Was Not Performed
Nitric Oxide
No History of Gestational Complication
TP53 Mutation Analysis Was Not Performed
personnel delegation
KIT Mutation Analysis Was Not Performed
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
communicable disease, nos
ATRX Mutation Analysis Was Not Performed
Nitric Oxide Measurement
Use of Smokeless Tobacco at Time of Diagnosis Negative
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
Intervention Not Given for Kawasaki Disease
primary health care
IDH Family Mutation Analysis Was Not Performed
Intercurrent Illness is Absent at Onset of Chief Complaint
Fluorescence In Situ Hybridization Was Not Performed
Patient was Not Previously Evaluated for Current Chief Complaint
Communicable Disorder
Patient was not Postmenopausal with no Prior Oophorectomy
Family History of Stomach Cancer Absent
Neither
Adjuvant Post-operative Chemotherapy Was Not Administered

---
https://www.who.int/fr/publications-detail/9789240073074
2023
Switzerland
technical report
mental disorders
Insurance
underinsured
problem, nos
significant other
patient participation
mental health
medically uninsured
Neurology
Mental health
Mental health
world health organization
insurance, health
mentally ill persons
neurology
nervous system diseases
deductibles and coinsurance
Disease
Diseases
communicable disease, nos
Noncommunicable Diseases

---
https://iris.who.int/handle/10665/370812
2023
Switzerland
technical report
NF1 Mutation Analysis Was Not Performed
Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Fluorescence In Situ Hybridization Was Not Performed
No History of Congenital Heart Disease
Has No Sibling
Chief Complaint Not Caused by Trauma
Intercurrent Illness is Absent at Onset of Chief Complaint
PDGFRA Mutation Analysis Was Not Performed
PTEN Mutation Analysis Was Not Performed
New Tumor Event After Initial Treatment Absent
Adjuvant Post-operative Immunological Therapy Was Not Administered
No History of Rheumatic Fever
Preoperative IV Opiates were not Administered
Preoperative IV Sedation was Not Administered
Tumor Progression Absent After Initial Treatment
Nitric Oxide
Chief Complaint was Not Witnessed
Evidence of Disease Absent after Completion of Therapy
Medication Not Taken
No Response to Intervention for Kawasaki Disease
EGFR Gene Amplification Negative
IDH Family Mutation Analysis Was Not Performed
Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up
Unemployed
Regional Anesthesia was not Administered
NON Mouse
Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed
TP53 Mutation Analysis Was Not Performed
ROS1 Rearrangement Analysis Was Not Performed
Radiation Was Not Administered as an Additional Treatment for a New Tumor Event
mentally ill persons
Other Preoperative IV Medications were not Administered
Additional Surgery for New Tumor Event Absent
Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed
Communicable Disorder
Additional Surgery for New Loco-Regional Tumor Event Was Not Performed
Physician Diagnosed Diabetes Absent
MET Mutation Analysis Was Not Performed
Use of Smokeless Tobacco at Time of Diagnosis Negative
EGFR Amplification Analysis Was Not Performed
History of Medical Treatment Absent
BRAF Mutation Analysis Was Not Performed
First Degree Family History Thyroid Cancer Negative
10q23/PTEN Locus Deletion Analysis Was Not Performed
1p/19q Deletion Analysis Was Not Performed
Adjuvant Post-operative Radiation Therapy Was Not Administered
Chemical/Occupational Exposure Absent
health status
Caffeine Not Routinely Consumed
ATRX Mutation Analysis Was Not Performed
KRAS Mutation Analysis Was Not Performed
Cancer History Absent
Local Anesthesia Agents were not Administered
No Known History of Alcohol Use
Therapeutic Ionizing Radiation to Head History Absent
Family History of Stomach Cancer Absent
Development Batch
ATRX Gene Mutation Negative
PTEN Gene Mutation Negative
Neither
Norway
Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered
No History of Kawasaki Disease
History of Colorectal Cancer Negative
EGFR Mutation Analysis Was Not Performed
Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event
Paraneoplastic Syndrome is Not Present
Another Form of Birth Control was not Used
Additional Surgery for New Metastatic Tumor Event Was Not Performed
Lymph Node Dissection Was Not Performed
No History of Myopathy
SDH Complex Mutation Analysis Was Not Performed
Negation
Routine Cytogenetics Were not Completed
Patient was Not Previously Evaluated for Current Chief Complaint
Hypertension Absent
No History of Gestational Complication
Additional Immunohistochemistry Was Not Performed
Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis
Additional Molecular Studies Were Not Performed
Radiation History Negative
NRAS Mutation Analysis Was Not Performed
Tumor Reoccurrence Absent After Initial Treatment
ALK Rearrangement Analysis Was Not Performed
Not Lost to Follow-Up
Regular Smokeless Tobacco Use for Six Weeks or More Negative
No Known History of Illicit Drug Use
IV Anesthesia was not Administered
Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection
Interferon Gamma Treatment was not Administered Prior to Specimen Resection
RET Rearrangement Analysis Was Not Performed
New Disease is not Multifocal
No History of Non-Cardiac Surgery
First Degree Family History of Primary Brain Tumor Negative
Nitric Oxide Measurement
Any Metastatic Diagnosis Absent
Radiation Therapy Not Received
BRAF Rearrangement Analysis Was Not Performed
Documentation Absent
Preoperative IV Antacids were not Administered
Adjuvant Post-operative Chemotherapy Was Not Administered
mental disorders
Minor Criteria for Rheumatic Heart Disease Not Present
Preoperative IV Antiemetics were not Administered
Chemotherapy Not Received
mental health
communicable disease, nos
Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
No History of Other Muscular Dystrophy or Glycogen Storage Disorder
First Degree Family History Cancer Negative
Intervention Not Given for Kawasaki Disease
No History of Neonatal Complication
Noncommunicable Diseases
Patient was not Postmenopausal with no Prior Oophorectomy
Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Neither Case or Control Status
ERBB2 Mutation Analysis Was Not Performed
Mental Health
Development Lot
IDH Family Wildtype
Maturation
KIT Mutation Analysis Was Not Performed
Adjuvant I-131 Therapy Negative
mental state, nos
Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event
MGMT Promoter Methylation Testing Was Not Performed

---
https://www.who.int/fr/publications-detail/9789240057067
2023
Switzerland
technical report
Applications
orientation
Noncommunicable Diseases
suggestive of
health facilities
Applications
indicators and reagents
orientation, nos
Diseases
nurse administrators
indication of
attention
attitude to health
communicable disease, nos
Disease
aftercare
Applications

---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-2-3-fevrier-mars-2023/surveillance-fondee-evenements-fournir-alerte-rapide-menaces-maladies-transmissibles.html
2023
Canada
journal article
organization and administration
Disease
communicable disease, nos
Diseases
impending
communicable diseases

---
https://www.theses.fr/2022LYO10023
2022
France
dissertations, academic
symptom assessment
mobile applications
mobility, nos
risk factors
Applications
Applications
Noncommunicable Diseases
Applications
communicable disease, nos
Disease
Diseases
risk factor
safety management

---
https://sides.uness.fr/corpus/M%C3%A9decine_interne:Endocardites_infectieuses
2021
France
educational course
bacterial endocarditis, nos
Endocarditis
internal medicine
Occupational medicine
risk
occupational health
Physicians
infective endocarditis
occupation, nos
endocarditis
hazardous substances
communicable disease, nos
occupational medicine
communicable diseases
internal medicine specialist
Diseases
Labor ; manpower ; population

---
https://apps.who.int/iris/bitstream/handle/10665/335828/WHO-2019-nCoV-Non-communicable_diseases-Evidence-2020.1-fre.pdf
2020
Switzerland
pneumonia, viral
coronavirus infections
technical report
Noncommunicable Diseases
Diseases
dataset
communicable disease, nos
Evidence-Based medicine
Disease
pandemics
dataset
COVID-19

---
https://apps.who.int/iris/bitstream/handle/10665/335826/WHO-2019-nCoV-Non-communicable_diseases-Policy_brief-2020.1-fre.pdf
2020
Switzerland
pneumonia, viral
coronavirus infections
technical report
Disease
pandemics
Diseases
Control
wrestling
Noncommunicable Diseases
communicable disease control
communicable disease, nos
wrestling
COVID-19

---
https://dumas.ccsd.cnrs.fr/dumas-02135825
2018
France
dissertations, academic
case study
acquired disease, nos
retrospective studies
sexually transmitted diseases
case reports
Kidney agenesis
Diseases
travel
Sexually transmitted disease
communicable disease, nos

---
https://www.medg.fr/surveillance-des-maladies-infectieuses-transmissibles
2018
France
teaching material
scientific and technical information
Diseases
infectious disease, nos
Disease
infectious diseases
communicable disease, nos
communicable diseases
organization and administration

---
https://syntheses.univ-rennes1.fr/search-theses/notice/view/rennes1-ori-wf-1-8285?height=500&width=900
2016
false
false
false
France
French
dissertations, academic
general practice
Relevance
communicable disease, nos
risk factor
generalized
reticulum
breast diseases
regional
risk factors
chronic disease
disease of breast, nos
communicable diseases
chronic disease, nos
general practitioners
epidemiologic factors
chronically ill
effect modifier, epidemiologic
epidemiologic studies

---
https://youtu.be/UJPcuSGMH4w
https://sesstim.univ-amu.fr/video-box/webinar-quantim-kankoe-sallah
2015
France
audiovisual aids
homo sapiens
Diseases
humans
Disease
communicable disease, nos
Methods
communicable diseases
protestantism
mobility, nos

---
http://www.who.int/entity/nmh/publications/ncd-status-report-2014/fr/index.html
2014
false
false
false
Switzerland
French
technical report
communicable diseases
communicable disease, nos
report
research report
albumin/globulin ratio

---